<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Immunity</journal-id>
      <journal-title-group>
        <journal-title>Immunity</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1074-7613</issn>
      <issn pub-type="epub">1097-4180</issn>
      <publisher>
        <publisher-name>Cell Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2862301</article-id>
      <article-id pub-id-type="pmid">20137987</article-id>
      <article-id pub-id-type="publisher-id">IMMUNI1844</article-id>
      <article-id pub-id-type="doi">10.1016/j.immuni.2009.11.013</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Aleksic</surname>
            <given-names>Milos</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dushek</surname>
            <given-names>Omer</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Hao</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shenderov</surname>
            <given-names>Eugene</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Ji-Li</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cerundolo</surname>
            <given-names>Vincenzo</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Coombs</surname>
            <given-names>Daniel</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van der Merwe</surname>
            <given-names>P. Anton</given-names>
          </name>
          <email>anton.vandermerwe@path.ox.ac.uk</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp">∗</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK</aff>
      <aff id="aff2"><label>2</label>Centre for Mathematical Biology, University of Oxford, Oxford OX1 3LB, UK</aff>
      <aff id="aff3"><label>3</label>Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK</aff>
      <aff id="aff4"><label>4</label>Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA</aff>
      <aff id="aff5"><label>5</label>Department of Mathematics and Institute of Applied Mathematics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada</aff>
      <author-notes>
        <corresp id="cor1"><label>∗</label>Corresponding author <email>anton.vandermerwe@path.ox.ac.uk</email></corresp>
        <fn id="fn1">
          <label>6</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>26</day>
        <month>2</month>
        <year>2010</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>26</day>
        <month>2</month>
        <year>2010</year>
      </pub-date>
      <volume>32</volume>
      <issue>2</issue>
      <fpage>163</fpage>
      <lpage>174</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>6</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>2</day>
          <month>10</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>11</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2010 ELL &amp; Excerpta Medica.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Summary</title>
        <p>T cell receptor (TCR) binding to diverse peptide-major histocompatibility complex (pMHC) ligands results in various degrees of T cell activation. Here we analyze which binding properties of the TCR-pMHC interaction are responsible for this variation in pMHC activation potency. We have analyzed activation of the 1G4 cytotoxic T lymphocyte clone by cognate pMHC variants and performed thorough correlation analysis of T cell activation with 1G4 TCR-pMHC binding properties measured in solution. We found that both the on rate (k<sub>on</sub>) and off rate (k<sub>off</sub>) contribute to activation potency. Based on our results, we propose a model in which rapid TCR rebinding to the same pMHC after chemical dissociation increases the effective half-life or “confinement time” of a TCR-pMHC interaction. This confinement time model clarifies the role of k<sub>on</sub> in T cell activation and reconciles apparently contradictory reports on the role of TCR-pMHC binding kinetics and affinity in T cell activation.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <title>Highlights</title>
        <p>► Potency of peptide-MHC as an agonist for TCR signaling is dependent on k<sub>on</sub> and k<sub>off</sub> ► A TCR-pMHC confinement time model is proposed to account for these parameters ► The model proposes that TCRs rebind the same peptide-MHC before dissociating ► The model reconciles binding kinetics and affinity in T cell activation</p>
      </abstract>
      <kwd-group>
        <kwd>MOLIMMUNO</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>Introduction</title>
      <p>Specific activation of T cells by cognate antigen is the central event in mounting adaptive immune responses. The specificity of T cell activation is achieved by tightly regulated T cell receptor (TCR) recognition of antigenic peptides in complex with major histocompatibility complex (pMHC) glycoproteins presented by antigen-presenting cells (APCs) or target cells (<xref rid="bib8" ref-type="bibr">Burroughs and van der Merwe, 2007</xref>). Any given TCR has the ability to bind to a large number of distinct pMHCs, leading to various functional outcomes. Depending on the engaged pMHC, T cells can be activated (stronger or weaker agonist) or inactivated (antagonist), or pMHC binding can have no effect (null peptide) (<xref rid="bib20 bib27" ref-type="bibr">Germain and Stefanová, 1999; Kersh and Allen, 1996</xref>). Although it is generally accepted that the potency of pMHC depends on the “strength” of its binding to TCR, there is controversy over which of the chemical parameters governing binding are the primary determinants of successful signaling (<xref rid="bib27 bib42" ref-type="bibr">Kersh and Allen, 1996; van der Merwe, 2001</xref>).</p>
      <p>The mechanism of signal transduction across the T cell membrane upon binding of pMHC to TCR, a process termed TCR triggering, is also controversial. There are several proposed models that can be divided into three groups depending on whether they invoke aggregation, conformational change, or segregation of the TCR (<xref rid="bib16 bib15 bib42" ref-type="bibr">Choudhuri et al., 2005; Choudhuri and van der Merwe, 2007; van der Merwe, 2001</xref>). Understanding which TCR-pMHC binding properties determine the potency of pMHC will improve our understanding of the molecular processes that accompany TCR triggering and place constraints on TCR triggering models.</p>
      <p>The ability to predict the potency of pMHC based on the TCR-pMHC bond parameters will assist in the rational design of antitumor peptide vaccines, because many tumor-specific antigens provoke only weak immune responses that are incapable of eliminating all tumor cells. One well-studied tumor-associated protein is NY-ESO-1 (<xref rid="bib11" ref-type="bibr">Chen et al., 1997</xref>), which is presently a candidate antigen for antitumor vaccines being developed to enhance immune responses against a variety of tumors. One of the most immunogenic HLA-A2-restricted peptides derived from the NY-ESO-1 protein is NY-ESO-1<sub>157-165</sub> (ESO-9C peptide) (<xref rid="bib25" ref-type="bibr">Jäger et al., 1998</xref>). However, immune responses initiated by the peptide are still not sufficient for complete tumor elimination, possibly because of its instability (see below). The design of NY-ESO-1<sub>157-165</sub> altered peptide ligands (APLs) that induce a better antitumor response could have important therapeutic benefits (<xref rid="bib3 bib13 bib35 bib43" ref-type="bibr">Apostolopoulos et al., 2000; Chen et al., 2005; McMahan et al., 2006; Webb et al., 2004</xref>).</p>
      <p>The majority of published data supports either kinetic or affinity models of pMHC potency. Kinetic models (<xref rid="bib26 bib28 bib34" ref-type="bibr">Kalergis et al., 2001; Kersh et al., 1998; McKeithan, 1995</xref>) propose that a productive signal is transduced by the TCR provided it remains bound to pMHC for a minimum period of time. For example, the kinetic proofreading model postulates that a series of biochemical modifications accumulate at the bound TCR that are lost upon pMHC dissociation. A productive signal is transduced only if the pMHC remains bound long enough to allow the TCR to reach a critical modification. Direct and indirect support for the model has come from studies that have shown good correlation between the T cell response and the TCR-pMHC bond off rate (k<sub>off</sub>) (<xref rid="bib9 bib26 bib28 bib29 bib37" ref-type="bibr">Carreño et al., 2007; Kalergis et al., 2001; Kersh et al., 1998; Krogsgaard et al., 2003; Qi et al., 2006</xref>). The affinity model postulates that the total number of TCR-pMHC complexes formed at equilibrium is the primary determinant of the T cell response. In support of this model, a number of studies reported correlations between the TCR-pMHC dissociation constant (K<sub>D</sub>), but not k<sub>off</sub>, and the T cell response (<xref rid="bib2 bib7 bib23 bib35 bib40" ref-type="bibr">Andersen et al., 2001; Boulter et al., 2007; Holler and Kranz, 2003; McMahan et al., 2006; Tian et al., 2007</xref>).</p>
      <p>Many of the studies supporting the affinity and kinetic models of pMHC potency include examples of discrepancies in the correlations they report (<xref rid="bib1 bib4 bib24 bib29" ref-type="bibr">al-Ramadi et al., 1995; Baker et al., 2001; Hudrisier et al., 1998; Krogsgaard et al., 2003</xref>). Several factors may account for these discrepancies. First, the majority of studies were performed with small numbers of pMHC agonists, limiting the reliability of observed correlations. Second, assays of T cell activation were performed by stimulating cells with various pMHC without always fully controlling for differences in peptide processing, loading, and stability. Third, solution binding parameters were mainly measured at 25°C rather than 37°C, the relevant temperature at which functional assays are performed. Fourth, TCR-pMHC solution binding or three-dimensional (3D) binding properties might be different compared to functionally relevant membrane or two-dimensional (2D) binding properties, where both pMHC and TCR are immobilized to surfaces. In such a constrained environment, the likelihood of protein rebinding after chemical dissociation is greatly enhanced, which would probably have a large impact on its 2D k<sub>off</sub>. Finally, variations in measured TCR-pMHC bond affinity in the majority of studies result mostly from differences in k<sub>off</sub> rather than k<sub>on</sub>, potentially masking the importance that k<sub>on</sub> may have in T cell activation.</p>
      <p>In order to explore which binding properties determine pMHC potency, we have performed a detailed study of 1G4 TCR (<xref rid="bib13" ref-type="bibr">Chen et al., 2005</xref>) binding to a large set of various NY-ESO<sub>157-165</sub> altered peptide ligands in complex with either wild-type or mutated HLA-A2. In separate experiments, we analyzed the activation of the 1G4 cytotoxic T lymphocyte (CTL) clone (from which the 1G4 TCR was isolated) by either immobilized pMHC or peptide-pulsed APCs, precisely controlling for equal pMHC presentation. Detailed statistical analysis reveals that models of T cell activation based solely on K<sub>D</sub> or k<sub>off</sub> do not robustly fit the data. However, a model based on the postulated confinement time of the TCR-pMHC interaction explains our data set. The proposed model reduces to simpler models dependent solely on K<sub>D</sub> or k<sub>off</sub> in certain limits, and therefore reconciles observations from previous reports.</p>
    </sec>
    <sec id="sec2">
      <title>Results</title>
      <sec id="sec2.1">
        <title>Analysis of Binding Properties of 1G4 TCR Interaction with NY-ESO<sub>157-165</sub> APLs and HLA-A2 Mutants</title>
        <p>We first designed various NY-ESO<sub>157-165</sub> APLs and HLA-A2 mutants that bind to 1G4 TCR with a wide range of binding characteristics. It has been demonstrated that a substitution of the highly unstable cysteine amino acid to valine (ESO-9V) or leucine (ESO-9L) at the anchor position 165 of NY-ESO<sub>157-165</sub> improves loading efficacy of peptide onto HLA-A2 and its subsequent immunogenicity (<xref rid="bib12" ref-type="bibr">Chen et al., 2000</xref>). We produced a set of ESO-9V APLs by substituting amino acids at the positions 3, 4, 5, 6, 7, and 8 in the peptide. In addition, we have generated a set of HLA-A2 variants with various mutations within the 1G4 TCR binding “footprint” (<xref rid="bib13" ref-type="bibr">Chen et al., 2005</xref>) (R65, H70, H74, R75, V76, K146). The affinity, kinetics, and thermodynamics of 1G4 TCR binding to 17 pMHC variants (APLs and HLA-A2 mutants) were analyzed by SPR at 37°C (<xref rid="fig1" ref-type="fig">Figure 1</xref>; <xref rid="app2" ref-type="sec">Figure S1</xref> and <xref rid="app2" ref-type="sec">Table S1</xref> available online).</p>
      </sec>
      <sec id="sec2.2">
        <title>Activation of 1G4 CTLs by Immobilized or Cell-Presented pMHCs</title>
        <p>pMHC immobilized to planar surfaces is often used as an alternative to cell-based assays for T cell activation and is a potent inducer of many T cell functions (<xref rid="bib21 bib29" ref-type="bibr">González et al., 2005; Krogsgaard et al., 2003</xref>). An important advantage of this assay is that the pMHC dose is independent of peptide affinity for MHC and can be precisely controlled. Activation of 1G4 CTLs by pMHC variants was analyzed by measuring interferon-gamma (IFN-γ) secretion by cells stimulated by graded concentrations of pMHCs (<xref rid="fig2" ref-type="fig">Figures 2</xref>A–2C). The activation potency (EC<sub>50</sub>) of pMHCs was determined from the pMHC concentration that stimulated half-maximal IFN-γ secretion (<xref rid="app2" ref-type="sec">Table S1</xref>). To control for variation in pMHC stability and concentration, the amounts of immobilized pMHC were measured with a conformation-sensitive antibody (<xref rid="app2" ref-type="sec">Figures S2</xref>A–S2C).</p>
        <p>Although functional assays with plate-bound pMHC allow precise control of the amounts of ligand, they have the disadvantage of being unphysiological. We therefore also investigated the stimulatory effect of ESO-9V APLs in a more physiological, cellular context by performing a cytotoxicity assay. As target cells we used the transporter associated with antigen processing (TAP)-deficient T2 cell line (<xref rid="bib10" ref-type="bibr">Cerundolo et al., 1990</xref>) pulsed with various ESO-9V APLs, precisely matching for surface pMHC expression (<xref rid="fig2" ref-type="fig">Figures 2</xref>D and 2E). The relative potency (EC<sub>50</sub>) of peptides was determined from the dilution of peptide resulting in half-maximal lysis of target cells (<xref rid="app2" ref-type="sec">Table S1</xref>).</p>
        <p>We next explored which of the measured binding parameters governing the TCR-pMHC interaction are the best predictors of the T cell response. Correlations between pMHC potency in inducing T cell responses and 17 binding parameters (not all of which are independent) are shown in <xref rid="tbl1" ref-type="table">Table 1</xref>, a subset of which are plotted in <xref rid="fig3" ref-type="fig">Figure 3</xref>. We found significant correlations (R<sup>2</sup> &gt; 0.7, p &lt; 0.01) only with K<sub>D</sub> (<xref rid="fig3" ref-type="fig">Figure 3</xref>A), k<sub>off</sub> (<xref rid="fig3" ref-type="fig">Figure 3</xref>B), and parameters derived from these measurements (e.g., ΔG, ΔG<sup>‡</sup><sub>diss</sub>). There was a weak correlation with k<sub>on</sub> (<xref rid="fig3" ref-type="fig">Figure 3</xref>C) but no correlation with enthalpy change (<xref rid="fig3" ref-type="fig">Figure 3</xref>D) or activation enthalpy change of dissociation (<xref rid="fig3" ref-type="fig">Figure 3</xref>E), the significance of which is discussed below. Thus we found in two different functional assays that pMHC potency correlates with both K<sub>D</sub> and k<sub>off</sub>.</p>
      </sec>
      <sec id="sec2.3">
        <title>Removing Bias by Subset Analysis</title>
        <p>The T cell response correlated well with both K<sub>D</sub> and k<sub>off</sub> when examining the entire data set (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="fig3" ref-type="fig">Figures 3</xref>A and 3B). However, the correlation between K<sub>D</sub> and k<sub>off</sub> is strong (R<sup>2</sup> = 0.73) among the pMHC variants used in the present study (<xref rid="fig4" ref-type="fig">Figure 4</xref>A) as the k<sub>on</sub> varied somewhat less than the k<sub>off</sub> (<xref rid="fig1" ref-type="fig">Figure 1</xref>). This made it difficult to resolve whether K<sub>D</sub> or k<sub>off</sub> determine potency or to identify a contribution from k<sub>on</sub>. In order to investigate the contribution of k<sub>on</sub>, we extracted subsets of the entire data set (17 pMHC variants for IFN-γ assay) that contain fewer pMHC variants selected to minimize the correlation between K<sub>D</sub> and k<sub>off</sub> and thus maximize the variation in k<sub>on</sub>. When more than two peptides were removed, the correlation between K<sub>D</sub> and k<sub>off</sub> rapidly approached zero (<xref rid="fig4" ref-type="fig">Figure 4</xref>B). Next, we fitted both K<sub>D</sub> and k<sub>off</sub> models to these subsets (see <xref rid="sec4" ref-type="sec">Experimental Procedures</xref>). Surprisingly, we found that both exhibited a poor fit (reduced R<sup>2</sup> value) as the correlation between K<sub>D</sub> and k<sub>off</sub> was reduced and the variability in k<sub>on</sub> increased (<xref rid="fig4" ref-type="fig">Figure 4</xref>B). This is illustrated by the poor fits of both K<sub>D</sub> and k<sub>off</sub> for the subset of 13 pMHC variants (<xref rid="fig4" ref-type="fig">Figures 4</xref>C and 4D). In <xref rid="tbl2" ref-type="table">Table 2</xref> we summarize the fits (R<sup>2</sup> statistic) and their significance (p value). It is evident that once three or more pMHC variants are removed, neither K<sub>D</sub> nor k<sub>off</sub> correlate significantly with pMHC potency (p &gt; 0.05).</p>
        <p>The nine APLs used in the cytotoxicity assay also exhibited a large K<sub>D</sub>-k<sub>off</sub> correlation (R<sup>2</sup> = 0.89). However, it was not possible to perform the subset analysis because of the limited amount of data. Correlations for these nine APLs with IFN-γ release were similar to the cytotoxicity assay (not shown). Thus, pMHC potency cannot be described by either k<sub>off</sub> or K<sub>D</sub> for the present data set.</p>
      </sec>
      <sec id="sec2.4">
        <title>Importance of the TCR-pMHC Bond k<sub>on</sub> in a Model of Confinement Time</title>
        <p>The observation that the basic K<sub>D</sub> and k<sub>off</sub> models fit poorly when k<sub>on</sub> varies suggested that k<sub>on</sub> is an important determinant of the T cell response, which is consistent with the weak correlation that we observed with k<sub>on</sub> (<xref rid="fig3" ref-type="fig">Figure 3</xref>C). Motivated by these observations and recent experimental work (<xref rid="bib41" ref-type="bibr">Tolentino et al., 2008</xref>), we investigated a simple model whereby rapid rebinding of a TCR to the same pMHC molecule counters the effects of membrane diffusion (or transport), effectively confining TCR-pMHC, as schematically presented in <xref rid="fig5" ref-type="fig">Figure 5</xref>A. In this confinement time model, we can calculate the total time the TCR will be in complex with the same pMHC (integrated across multiple rebinding events) as T<sub>c</sub> = (k<sup>∗</sup><sub>on</sub> + k<sub>−</sub>)/(k<sub>−</sub>k<sub>off</sub>) and the total time the TCR will be unbound but within the reaction radius (i.e., binding range) of the pMHC as T<sub>f</sub> = 1/k<sub>−</sub>. In these equations, k<sup>∗</sup><sub>on</sub> (in units of s<sup>−1</sup>) is the intrinsic localized on rate between a single TCR-pMHC pair and is related to the solution on rate by a multiplicative factor (see <xref rid="sec4" ref-type="sec">Experimental Procedures</xref>), and k<sub>−</sub> (in units of s<sup>−1</sup>) is the rate at which TCR-pMHC move (diffuse) apart. With reasonable parameters we found that T<sub>c</sub> &gt; &gt; T<sub>f</sub> (see <xref rid="sec4" ref-type="sec">Experimental Procedures</xref>), indicating that the total time that TCR and pMHC are confined to one another is determined by T<sub>c</sub>. The reciprocal of T<sub>c</sub> determines an effective off rate (k<sup>∗</sup><sub>off</sub>) that captures the rate at which TCR and pMHC move apart,<disp-formula><mml:math id="M1" altimg="si1.gif" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:mtext>_</mml:mtext><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mo>−</mml:mo></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mtext>.</mml:mtext></mml:mrow></mml:mrow></mml:math></disp-formula></p>
        <p>This expression reflects the rate of unbinding and the probability of moving apart before rebinding. A full description of the model can be found in <xref rid="sec4" ref-type="sec">Experimental Procedures</xref>.</p>
        <p>In certain limits, the confinement time model reduces to the basic models. When the intrinsic on rate is large compared to the diffusive rate (k<sup>∗</sup><sub>on</sub> &gt; &gt; k<sub>−</sub>), the confinement time is directly proportional to K<sub>D</sub> (k<sup>∗</sup><sub>off</sub> = k<sub>+</sub>K<sub>D</sub>). In contrast, when k<sup>∗</sup><sub>on</sub> &lt; &lt; k<sub>−</sub>, the effective off rate is simply k<sup>∗</sup><sub>off</sub> = k<sub>off</sub> because TCR-pMHC move apart without rebinding. Measurements of binding constants represent intrinsic rates because experiments were performed in a flow chamber (BIAcore) under conditions that minimize rebinding events. In other words, dissociation in the flow chamber leads to transport rather than localized rebinding.</p>
        <p>In <xref rid="fig5" ref-type="fig">Figure 5</xref>B we showed the results of fitting the confinement time model to the entire data set. We found an improved correlation (R<sup>2</sup> = 0.83) compared to the basic models of K<sub>D</sub> and k<sub>off</sub>. Next, we fitted the confinement time model to the pMHC variant subsets described in the previous section and found that the R<sup>2</sup> statistic remained large for all subsets (Figures <xref rid="fig4" ref-type="fig">4</xref>B and <xref rid="fig5" ref-type="fig">5</xref>C for the 13 pMHC subsets). In contrast to the K<sub>D</sub> and k<sub>off</sub> models, we found that the confinement time model remained significant (p &lt; 0.05) for all except one subset of the data (<xref rid="tbl2" ref-type="table">Table 2</xref>).</p>
      </sec>
      <sec id="sec2.5">
        <title>Potential Effects of Molecular Flexibility</title>
        <p>It has been previously proposed that the heat capacity is important in relating the solution k<sub>off</sub> to the physiological membrane k<sub>off</sub> because heat capacity reflects molecular flexibility, and this may affect the dissociation rate of membrane-tethered molecules (<xref rid="bib29 bib37" ref-type="bibr">Krogsgaard et al., 2003; Qi et al., 2006</xref>). This molecular flexibility model, as applied to the present data, predicts that the T cell response will be related to k<sub>off</sub>exp(bΔC<sub>p</sub>), where b is a constant (see <xref rid="sec4" ref-type="sec">Experimental Procedures</xref> for details on data fitting). Shown in <xref rid="fig5" ref-type="fig">Figure 5</xref>D are the results of fitting the molecular flexibility model to the entire data set. We find a small improvement in the R<sup>2</sup> statistic compared to a model of k<sub>off</sub> alone (<xref rid="fig3" ref-type="fig">Figure 3</xref>B). Moreover, performing the subset analysis (Figures <xref rid="fig4" ref-type="fig">4</xref>B and <xref rid="fig5" ref-type="fig">5</xref>E and <xref rid="tbl2" ref-type="table">Table 2</xref>), we observed improved R<sup>2</sup> values for only two data subsets (five or seven pMHC variants removed).</p>
        <p>The processes of molecular flexibility and confinement time are not mutually exclusive. We therefore formulated the combined model and performed data fitting (see <xref rid="sec4" ref-type="sec">Experimental Procedures</xref>). The combined model depends on k<sub>off</sub>, k<sub>on</sub>, and ΔC<sub>p</sub> and has four free parameters. In <xref rid="fig5" ref-type="fig">Figure 5</xref>F we plot the results of data fitting to this model by using the entire data set and find, as expected, an improved fit (R<sup>2</sup> = 0.89). Results from the subset analysis can be seen in <xref rid="fig4" ref-type="fig">Figure 4</xref>B and <xref rid="tbl2" ref-type="table">Table 2</xref> and are visualized for the 13 pMHC subsets in <xref rid="fig5" ref-type="fig">Figures 5</xref>E and 5G for the molecular flexibility and the combined model, respectively. Thus, the molecular flexibility model does not account for the potency of the pMHC variants in this system.</p>
      </sec>
      <sec id="sec2.6">
        <title>A Statistical Test for Model Comparisons Reveals the Importance of the Confinement Time Model</title>
        <p>It is not surprising that the confinement time (three free parameters), molecular flexibility (three free parameters), and combined models (four free parameters) exhibit improved R<sup>2</sup> values compared to the simple models of K<sub>D</sub> and k<sub>off</sub> (two free parameters). In order to determine whether the increase in the quality of the fit, as reported by an increase in R<sup>2</sup>, is not simply due to an increase in the number of free parameters, we performed an F-test for nested models. This statistical test provides a p value for the null hypothesis that the simpler model is sufficient to explain the data (<xref rid="bib36" ref-type="bibr">Motulsky and Christopoulos, 2004</xref>) (see <xref rid="sec4" ref-type="sec">Experimental Procedures</xref>). In <xref rid="tbl2" ref-type="table">Table 2</xref> we report p values based on this statistical test. A p value below 0.05 indicates that the model with more parameters significantly improves the fit. We found that the confinement time model provided a statistically significant (p &lt; 0.05) improvement in the fit compared to the simple models of K<sub>D</sub> and k<sub>off</sub>, with the exception of three subsets. In contrast, the molecular flexibility model significantly improved the fit (compared to the basic k<sub>off</sub>) only for the subsets with five or seven pMHC variants removed. The combined confinement time and molecular flexibility model (four free parameters) was a better descriptor of the data (p &lt; 0.05) compared to molecular flexibility alone but only in some instances did it significantly improve the fit compared to the confinement time model.</p>
        <p>In summary, we find that the confinement time model provides a more robust description of the data than does the molecular flexibility model. However, a combination of the two models is also able to improve the fit in some circumstances.</p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>Discussion</title>
      <p>In our study we have determined the functional response of 1G4 CTLs to a panel of 17 pMHC variants consisting of APLs and HLA-A2 mutants. With this large data set, we have found that pMHC potency is not well correlated to either K<sub>D</sub> or k<sub>off</sub> when examining data subsets with larger variability in k<sub>on</sub>. We found that a model of TCR-pMHC confinement time provided consistently larger correlations than did alternative models. By using rigorous statistical analysis (an F-test for nested models), we have shown that these improved correlations are not simply due to the addition of extra fitting parameters.</p>
      <p>Our study differs from previous studies in that it examines a larger number of pMHC variants with a wide variation in k<sub>on</sub>, enabling us to clarify the role of k<sub>on</sub> in pMHC potency. Most previous studies are nevertheless consistent with, and therefore support, our proposed confinement time model. For example, in a study in which the k<sub>on</sub> varied little or much less than the k<sub>off</sub>, it was found that the pMHC potency correlates with both k<sub>off</sub> and K<sub>D</sub> (<xref rid="bib14" ref-type="bibr">Chervin et al., 2009</xref>). Other studies have reported a correlation between pMHC potency and either K<sub>D</sub> (<xref rid="bib2 bib7 bib23 bib35 bib40" ref-type="bibr">Andersen et al., 2001; Boulter et al., 2007; Holler and Kranz, 2003; McMahan et al., 2006; Tian et al., 2007</xref>) or k<sub>off</sub> (<xref rid="bib9 bib26 bib28 bib29 bib37" ref-type="bibr">Carreño et al., 2007; Kalergis et al., 2001; Kersh et al., 1998; Krogsgaard et al., 2003; Qi et al., 2006</xref>). This apparent conflict can be reconciled because the confinement time model reduces to the k<sub>off</sub> or K<sub>D</sub> models under certain conditions. When there is little rebinding (k<sub>on</sub> is small), then k<sup>∗</sup><sub>off</sub> approaches k<sub>off,</sub> whereas if rebinding is frequent (k<sub>on</sub> is large), then k<sup>∗</sup><sub>off</sub> approaches K<sub>D</sub>. In agreement with this, in studies where TCR-pMHC interactions had a large k<sub>on</sub> (&gt;10<sup>5</sup> M<sup>−1</sup>s<sup>−1</sup>), pMHC potency correlated well with K<sub>D</sub> (<xref rid="bib23 bib40" ref-type="bibr">Holler and Kranz, 2003; Tian et al., 2007</xref>), whereas in studies where TCR-pMHC interactions had a small k<sub>on</sub> (∼10<sup>3</sup> M<sup>−1</sup>s<sup>−1</sup>), pMHC potency correlated well with k<sub>off</sub> (<xref rid="bib29" ref-type="bibr">Krogsgaard et al., 2003</xref>). In the present study, the k<sub>on</sub> values were intermediate (∼10<sup>4</sup> M<sup>−1</sup>s<sup>−1</sup>), providing an explanation as to why the full TCR-pMHC confinement time model, but not the reduced models, provided the best description of the data. In conclusion, the confinement time model reconciles, and is supported by, previously conflicting reports of the determinants of pMHC potency.</p>
      <p>Two independent lines of evidence support a confinement time model. First, there is evidence that interactions at the cell-cell interface have longer half-lives than predicted from measurements in solution (<xref rid="bib22 bib41" ref-type="bibr">Grakoui et al., 1999; Tolentino et al., 2008</xref>). Fluorescence recovery after photobleaching (FRAP) experiments have demonstrated that the effective exchange lifetime of a CD2-CD58 interaction in the membrane is 100 times longer than the lifetime measured in solution (<xref rid="bib41" ref-type="bibr">Tolentino et al., 2008</xref>). Given that the intrinsic half life of a membrane-tethered interaction would be expected to be shorter because it is subjected to mechanical forces (<xref rid="bib6" ref-type="bibr">Bell, 1979</xref>), this suggests that immediate rebinding after dissociation must be occurring. In agreement with this observation, we find that the calculated k<sup>∗</sup><sub>off</sub> of TCR-pMHC interaction (∼0.1 s<sup>−1</sup>) is 10 times slower than the k<sub>off</sub> measured in solution (∼1 s<sup>−1</sup>). We note that several factors, such as remodeling of cellular protrusions and thermal fluctuations that alter the intermembrane separation, will exert a mechanical force on the TCR-pMHC bond and therefore increase the TCR-pMHC k<sup>∗</sup><sub>off</sub>. Therefore, the estimate of k<sup>∗</sup><sub>off</sub> is probably a lower limit and the actual k<sup>∗</sup><sub>off</sub> may be larger. Direct measurements of TCR-pMHC bond k<sup>∗</sup><sub>off</sub> at cell-cell interfaces will inform on these aspects. A second line of evidence supporting the confinement time model is the finding by several groups that increasing the mobility of pMHC on the cell surface inhibits T cell antigen recognition (<xref rid="bib32 bib38 bib44" ref-type="bibr">Luxembourg et al., 1998; Segura et al., 2008; Wettstein et al., 1991</xref>). The confinement time model can account for this hitherto unexplained finding because it predicts that an increase in pMHC mobility will decrease rebinding and therefore increase the effective k<sub>off</sub>.</p>
      <p>It has been pointed out that the TCR-pMHC interaction, like all interactions at a cell-cell interface, would be subjected to mechanical forces, raising the possibility that the mechanical strength of TCR-pMHC interaction might be an important determinant of pMHC potency (<xref rid="bib42" ref-type="bibr">van der Merwe, 2001</xref>). More recently it has been proposed that a mechanical pulling force exerted by pMHC binding could induce a conformational change in TCR-CD3 complex that could contribute to TCR triggering (<xref rid="bib15 bib33" ref-type="bibr">Choudhuri and van der Merwe, 2007; Ma et al., 2008</xref>). It has been suggested that the activation enthalpy of dissociation (ΔH<sup>‡</sup><sub>diss</sub>) should correlate with mechanical strength, since, according to transition state theory, it is a measure of the number of bonds that must be broken during dissociation (<xref rid="bib31" ref-type="bibr">Leckband, 2000</xref>), although this remains to be proven. For this reason, we have analyzed transition state thermodynamics and determined the ΔH<sup>‡</sup><sub>diss</sub> for 1G4 TCR interaction with the pMHC variants. However, we failed to find a correlation of T cell activation with ΔH<sup>‡</sup><sub>diss</sub> alone or in combination with any other binding characteristic (not shown). Because it remains unclear what, if any, solution binding parameter(s) correlate(s) precisely with mechanical strength, direct measurements of the mechanical properties of TCR-pMHC interactions (e.g., by atomic force microscopy) are probably required to elucidate the role of mechanical forces in TCR triggering and T cell activation.</p>
      <p>The molecular flexibility model (<xref rid="bib37" ref-type="bibr">Qi et al., 2006</xref>) proposes that for some, conformationally flexible TCR-pMHC interactions, immobilization in the membrane may increase the TCR-pMHC bond lifetime compared to solution measurements. The model predicts a simple relationship between the solution and membrane lifetime that depends on ΔC<sub>p</sub>. We did not find substantial effects of molecular flexibility for the data set in the present study. We note, however, that structural studies indicate that the 1G4 TCR undergoes only minor conformational changes during binding to 9V-ESO-HLA-A2 (<xref rid="bib13" ref-type="bibr">Chen et al., 2005</xref>). In addition, the ΔC<sub>p</sub> values, which range from −0.37 to −0.70 kcal/mol K, are much smaller and less variable than those previously reported by Krogsgaard et al. for the 2B4 TCR (<xref rid="bib29 bib37" ref-type="bibr">Krogsgaard et al., 2003; Qi et al., 2006</xref>). Therefore, the importance of molecular flexibility (and ΔC<sub>p</sub>) may vary between different TCR-pMHC systems and is hence an important topic for future investigation.</p>
      <p>The observation that pMHC potency is determined by the confinement time of TCR-pMHC has implications for models of pMHC detection and discrimination. This finding implies that the signaling state of the TCR persists during brief chemical dissociation events. The consequence of this signal persistence is that pMHC detection is based on a threshold in the confinement time and therefore, discrimination is based on both k<sub>on</sub> and the k<sub>off</sub>. Moreover, the ability of a T cell to discriminate between weak and strong agonist pMHC could be a result of a slower k<sub>on</sub> rather than a faster k<sub>off</sub>. A mathematical model that explicitly accounts for rebinding and signal persistence at the TCR confirms these observations and shows that, in certain parameter regimes, discrimination based on k<sub>on</sub> can be just as sharp as k<sub>off</sub> (<xref rid="bib19" ref-type="bibr">Dushek et al., 2009</xref>). In addition, requiring pMHC with fast off rates to rebind TCR multiple times before productive signaling is initiated could act to reduce spurious signals generated by a high density of endogenous pMHC (fast off rates, small on rates) that are unlikely to rebind TCR.</p>
      <p>As noted in the <xref rid="sec1" ref-type="sec">Introduction</xref>, the mechanism of TCR triggering remains controversial. Three main types of models have been proposed invoking conformation change, aggregation, or segregation of the TCR-CD3 complex upon pMHC engagement, and these mechanisms are not mutually exclusive (reviewed in <xref rid="bib15" ref-type="bibr">Choudhuri and van der Merwe, 2007</xref>). Although our study does not directly address mechanisms of TCR triggering, our finding that T cell activation depends on the confinement time places important constraints on the details of these models. The key constraint is that the TCR signaling mechanism is not disrupted or interrupted when the TCR dissociates briefly between rebinding events. It follows that conformational change in the TCR-CD3 complex would either need to be stable between rebinding or there would need to be an early rapid modification that is stable between rebinding events but will be readily reversed after complete dissociation. In short, there is a requirement for some memory mechanism at the level of the TCR after chemical dissociation. To our knowledge no existing models of conformational change explicitly propose a memory mechanism.</p>
      <p>The kinetic-segregation (K-S) model of TCR triggering posits that pMHC binding leads to confinement of the TCR-CD3 complex within close-contact zones deficient in tyrosine phosphatases and/or enriched in Src tyrosine kinases (<xref rid="bib17" ref-type="bibr">Davis and van der Merwe, 1996</xref>). The confinement time model would not allow lateral TCR-CD3 diffusion out of close contact zones during the brief periods between rebinding events, so it is entirely compatible with the K-S model without any modifications. The essence of aggregation models is the induced proximity of TCR-CD3 complexes after pMHC engagement. In these models termination of signaling requires diffusion of TCR-CD3 complexes, and the confinement time model requires that there is no diffusion between rebinding, so it follows that aggregation models are also compatible with the importance of confinement time. It is noteworthy that either the aggregation or K-S mechanism could provide the “memory” necessary for conformational change models to be compatible with the confinement time model. Thus any model that combined the aggregation or segregation with conformational change would be compatible with confinement time model.</p>
      <p>Protein interactions in the membrane environment are complex and dynamic and differ significantly from interactions in solution. Our model aims to capture the most important aspects of this complexity but it has to be mentioned that, although improved over simple models, correlation of T cell activation with confinement time calculated from the solution properties of the TCR-pMHC is not perfect. One possible explanation for this is that these solution measurements do not correlate perfectly with the actual binding properties of membrane-associated molecules. Direct measurements of 2D binding kinetics of membrane-associated TCR and pMHC are needed to address this point fully. Another possible explanation for this imperfect correlation is that conformational changes in the TCR are required for TCR triggering (<xref rid="bib5" ref-type="bibr">Beddoe et al., 2009</xref>) and pMHC variants differ in their propensity to induce the required conformational change.</p>
      <p>It is likely that coreceptor (CD8) binding to pMHC will increase the TCR-pMHC confinement time. If the contribution of coreceptors is similar for all pMHC variants, coreceptor binding may not affect the relationship between TCR-pMHC binding parameters and T cell activation. Our finding that confinement time correlated with pMHC potency in a system in which CD8 engagement occurs is consistent with this. Point mutations in HLA-A2 that disrupt CD8 binding strongly abrogate recognition by 1G4 T cells (<xref rid="bib13" ref-type="bibr">Chen et al., 2005</xref>), rendering them unresponsive to low-affinity pMHC variants (K<sub>D</sub> &gt; 20 μM). Unfortunately this precluded an analysis of the contribution of CD8 to pMHC potency in this system because most pMHC variants have a low affinity.</p>
      <p>In conclusion, we have demonstrated the importance of TCR-pMHC k<sub>on</sub> in determining the outcome of T cell antigen recognition. We show that the dependence on k<sub>on</sub> can best be accounted for by a confinement time model, in which there is repeated rebinding after TCR-pMHC chemical dissociation and the outcome of TCR engagement is dependent on the length of time until complete dissociation. Our model can account for previous, apparently contradictory, findings and provide an explanation for the hitherto unexplained dependence of TCR triggering on pMHC mobility. Although this confinement time model is compatible with existing aggregation or segregation models of TCR triggering, it requires modification of conformational change models to include a mechanism for “memory” between rebinding events.</p>
    </sec>
    <sec sec-type="methods" id="sec4">
      <title>Experimental Procedures</title>
      <sec id="sec4.1">
        <title>Surface Plasmon Resonance</title>
        <p>Protein subunits of 1G4 TCR and HLA-A2 were expressed in <italic>E. coli</italic>, purified, and refolded in vitro, as described in <xref rid="app2" ref-type="sec">Supplemental Experimental Procedures</xref>. Binding properties of 1G4 TCR interaction with ESO-9V pMHC variants were analyzed by SPR on a BIAcore 3000 (GE Healthcare Life Sciences, Little Chalfont Bucks, UK). Binding affinity was analyzed by measuring equilibrium binding of graded concentrations of 1G4 TCR to immobilized pMHC. Kinetic data were obtained by injecting 1G4 TCR over the immobilized pMHC and analysis of the dissociation phase curve fitting in BIAevaluation software. Binding thermodynamics was analyzed by measuring affinity and kinetics at the range of temperatures, calculating binding energy (ΔG and Δ<sup>‡</sup>G<sub>diss</sub>), and fitting data to the van't Hoff equation. Details of binding analysis by SPR can be found in <xref rid="app2" ref-type="sec">Supplemental Experimental Procedures</xref>.</p>
      </sec>
      <sec id="sec4.2">
        <title>Assays for 1G4 CTL Activation by pMHC Variants</title>
        <p>1G4 CTLs were stimulated by graded levels of plate-immobilized pMHC for 4 hr and levels of released IFN-γ was measured from the cell supernatant by ELISA. Cytotoxic response of 1G4 CTLs to various ESO-9V APLs was analyzed by incubating 1G4 CTLs with <sup>51</sup>Cr loaded T2 cells pulsed with various ESO-9V APLs for 4 hr and measuring levels of released <sup>51</sup>Cr from lysed T2 cells. Further details can be found in the <xref rid="app2" ref-type="sec">Supplemental Experimental Procedures</xref>.</p>
      </sec>
      <sec id="sec4.3">
        <title>Model of TCR-pMHC Confinement Time</title>
        <p>We capture the effect of TCR-pMHC confinement via the theory of diffusion-limited reactions on membranes (<xref rid="bib30 bib39" ref-type="bibr">Lauffenburger and Linderman, 1993; Shoup and Szabo, 1982</xref>). The model can be represented as follows:<disp-formula><mml:math id="M2" altimg="si2.gif" overflow="scroll"><mml:mrow><mml:mi>R</mml:mi><mml:mo>+</mml:mo><mml:mi>P</mml:mi><mml:munderover><mml:mo>↔</mml:mo><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mo>−</mml:mo></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mo>+</mml:mo></mml:msub></mml:mrow></mml:munderover><mml:mi>F</mml:mi><mml:munderover><mml:mo>↔</mml:mo><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:munderover><mml:mi>C</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>where TCR (R) and pMHC (P) first form an encounter complex (F), where the two molecules are within physical proximity but chemically dissociated, and subsequently they may bind to form a TCR-pMHC complex (C). The diffusion-limited on rate (in units of μm<sup>2</sup>/s) is given by k<sub>+</sub> = 2πD/ln(b/s), where D is the diffusion coefficient, b is the mean distance between TCR, and s is the reaction radius (roughly the size of a TCR). The remaining microscopic rates (k<sub>off</sub>, k<sup>∗</sup><sub>on</sub>, k<sub>−</sub>), on the scale of a single TCR-pMHC, are all first order (in units of s<sup>−1</sup>) and are related to the experimentally measured macroscopic rates (see below). Assuming that TCR-pMHC are initially bound, we can calculate the mean time that the molecules will spend in each state before moving apart,<disp-formula><mml:math id="M3" altimg="si3.gif" overflow="scroll"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mo>−</mml:mo></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula><disp-formula><mml:math id="M4" altimg="si4.gif" overflow="scroll"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mo>−</mml:mo></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mo>−</mml:mo></mml:msub></mml:mrow></mml:mfrac><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>where T<italic><sub>f</sub></italic> and T<italic><sub>c</sub></italic> are the time spent in the unbound (F) and bound (C) states, respectively, integrated across multiple rebinding events. The TCR-pMHC bond lifetime (1/k<sub>off</sub>) is much larger than 1/k<sub>−</sub> (see below) and therefore T<italic><sub>c</sub></italic> &gt; &gt; T<italic><sub>f</sub></italic>, indicating that TCR-pMHC spend negligible time within physical proximity but chemically unbound. The total TCR-pMHC confinement time is then T = T<italic><sub>c</sub></italic>, whose reciprocal gives an effective off rate describing the rate at which TCR-pMHC move apart, k<sup>∗</sup><sub>off</sub> = 1/T (see <xref rid="sec2" ref-type="sec">Results</xref>). We note that a macroscopic model of pMHC confinement time to a cluster of TCR predicts that the confinement time is governed by K<sub>D</sub> (<xref rid="bib18" ref-type="bibr">Dushek and Coombs, 2008</xref>).</p>
        <p>The rates in the model (k<sup>∗</sup><sub>on</sub>, k<sub>-</sub>) are first order because we are considering reactions between proteins in physical proximity and it is reasonable to assume that they are proportional to macroscopic parameters that are measured in experiments. The solution on rate (k<sub>on</sub>) in units of M<sup>−1</sup>s<sup>−1</sup> can be converted to a 2D membrane on rate (in units of μm<sup>2</sup>/s) by a confinement length (L) with a factor of 10<sup>15</sup>/(N<sub>A</sub>L), where N<sub>A</sub> is Avogadro's number. The 2D membrane on rate can be related to the intrinsic on rate (k<sup>∗</sup><sub>on</sub> in units of s<sup>−1</sup>) by the effective local TCR concentration (1 TCR in an area A = πs<sup>2</sup>, where s is the previously defined reaction radius). We can therefore relate the experimentally measured solution on rate to the intrinsic on rate by a multiplicative factor, k<sup>∗</sup><sub>on</sub> = σk<sub>on</sub> where σ = 10<sup>15</sup>/(N<sub>A</sub>LA). Assuming that diffusion is the primary determinant of the relative TCR-pMHC mobility, the rate at which TCR-pMHC move apart when unbound (k<sub>−</sub>) is directly related to the diffusion-limited membrane on rate; k<sub>−</sub> = k<sub>+</sub>/A. By using reasonable parameters (D = 0.05 μm<sup>2</sup>/s, s = 0.005 μm, b = 0.05 μm, and a TCR concentration of 100 μm<sup>−2</sup>), we calculated that k<sub>+</sub> ≈ 0.1 μm<sup>2</sup>/s and therefore 1/k<sub>−</sub> is several orders of magnitude smaller than 1/k<sub>off</sub>, indicating that the TCR-pMHC confinement time is dominated by the time in the bound state (T<italic><sub>c</sub></italic> &gt; &gt; T<italic><sub>f</sub></italic>). The exact relationship between the intrinsic and macroscopic rates is not important for our conclusions.</p>
      </sec>
      <sec id="sec4.4">
        <title>Statistical Analysis and Model Fitting</title>
        <p>The equations used to fit the five models we have focused on (<xref rid="fig4" ref-type="fig">Figure 4</xref>B) are as follows:<disp-formula><alternatives><textual-form specific-use="jats-markup">y=b<sub>0</sub>+b<sub>1</sub> K<sub>D</sub>, </textual-form><mml:math id="M5" altimg="si5.gif" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>=</mml:mo><mml:mtext>b</mml:mtext></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>b</mml:mtext><mml:mn>1</mml:mn></mml:msub><mml:mspace width="0.25em"/><mml:msub><mml:mtext>K</mml:mtext><mml:mtext>D</mml:mtext></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula><disp-formula><alternatives><textual-form specific-use="jats-markup">y=b<sub>0</sub>+b<sub>1</sub> k<sub>off</sub>, </textual-form><mml:math id="M6" altimg="si6.gif" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>=</mml:mo><mml:mtext>b</mml:mtext></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>b</mml:mtext><mml:mn>1</mml:mn></mml:msub><mml:mspace width="0.25em"/><mml:msub><mml:mtext>k</mml:mtext><mml:mrow><mml:mtext>off</mml:mtext></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula><disp-formula><alternatives><textual-form specific-use="jats-markup">y=b<sub>0</sub>+b<sub>1</sub> k<sub>off</sub> / (k<sub>on</sub>+b<sub>2</sub>),  Confinement Time (CT)</textual-form><mml:math id="M7" altimg="si7.gif" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>=</mml:mo><mml:mtext>b</mml:mtext></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>b</mml:mtext><mml:mn>1</mml:mn></mml:msub><mml:mspace width="0.25em"/><mml:msub><mml:mtext>k</mml:mtext><mml:mrow><mml:mtext>off</mml:mtext></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mtext>k</mml:mtext><mml:mrow><mml:mtext>on</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>b</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mtext>Confinement</mml:mtext><mml:mspace width="0.25em"/><mml:mtext>Time</mml:mtext><mml:mspace width="0.25em"/><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>CT</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula><disp-formula><alternatives><textual-form specific-use="jats-markup">y=b<sub>0</sub>+b<sub>1</sub> k<sub>off</sub>exp(b<sub>2</sub>ΔC<sub>p</sub>),  Molecular Flexiblity(MF)</textual-form><mml:math id="M8" altimg="si8.gif" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>=</mml:mo><mml:mtext>b</mml:mtext></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>b</mml:mtext><mml:mn>1</mml:mn></mml:msub><mml:mspace width="0.25em"/><mml:msub><mml:mtext>k</mml:mtext><mml:mrow><mml:mtext>off</mml:mtext></mml:mrow></mml:msub><mml:mi>exp</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mtext>b</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>Δ</mml:mo><mml:msub><mml:mtext>C</mml:mtext><mml:mtext>p</mml:mtext></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mtext>Molecular</mml:mtext><mml:mspace width="0.25em"/><mml:mtext>Flexiblity</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>MF</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula><disp-formula><alternatives><textual-form specific-use="jats-markup">y=b<sub>0</sub>+b<sub>1</sub> k<sub>off</sub>exp(b<sub>3</sub>ΔC<sub>p</sub>) / (k<sub>on</sub>+b<sub>2</sub>),  Combined CT+MF, </textual-form><mml:math id="M9" altimg="si9.gif" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>=</mml:mo><mml:mtext>b</mml:mtext></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>b</mml:mtext><mml:mn>1</mml:mn></mml:msub><mml:mspace width="0.25em"/><mml:msub><mml:mtext>k</mml:mtext><mml:mrow><mml:mtext>off</mml:mtext></mml:mrow></mml:msub><mml:mi>exp</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mtext>b</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:mo>Δ</mml:mo><mml:msub><mml:mtext>C</mml:mtext><mml:mtext>p</mml:mtext></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mtext>k</mml:mtext><mml:mrow><mml:mtext>on</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>b</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mtext>Combined</mml:mtext><mml:mspace width="0.25em"/><mml:mtext>CT</mml:mtext><mml:mo>+</mml:mo><mml:mtext>MF</mml:mtext><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>where y is the measure of pMHC potency (i.e., y = EC<sub>50</sub>) and b<sub>i</sub> are free parameters. All data fitting was performed with the Matlab function lsqcurvefit. Reported R<sup>2</sup> statistics and associated p values (calculated by an F-test) are computed with standard methods. The models we investigate contain different numbers of free parameters and therefore it is not possible to directly compare the R<sup>2</sup> statistic because additional parameters will always lead to larger R<sup>2</sup> values. To determine the significance of increased R<sup>2</sup> values in models with more parameters, we compute an F-score (<xref rid="bib36" ref-type="bibr">Motulsky and Christopoulos, 2004</xref>):<disp-formula><alternatives><textual-form specific-use="jats-markup"><italic>F</italic>=½</textual-form><mml:math id="M10" altimg="si10.gif" overflow="scroll"><mml:mrow><mml:mi>F</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>S</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>−</mml:mo><mml:mi>S</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>where SSR is the sum squared residuals, p is the number of free or fitted parameters, and n is the number of data points. The subscript 1 refers to the simpler model with fewer parameters. A p value is computed based on the F-score from the F-distribution with (p<sub>2</sub> – p<sub>1</sub>, n – p<sub>2</sub>) degrees of freedom and is used to test the null hypothesis that the simpler model (with fewer parameters) is sufficient to explain the data (see <xref rid="tbl2" ref-type="table">Table 2</xref>).</p>
      </sec>
      <sec id="sec4.5">
        <title>Representation of Effective Off Rates</title>
        <p>In order to explore the importance of TCR-pMHC confinement time, we performed data fitting with the effective off rate (y = b<sub>0</sub> + b′<sub>1</sub> k<sup>∗</sup><sub>off</sub>). By using the definition of k<sup>∗</sup><sub>off</sub>, we fitted the following equation: y = b<sub>0</sub> + b<sub>1</sub> k<sub>off</sub>/(k<sub>on</sub> + b<sub>2</sub>). In this equation, b<sub>1</sub> = b′<sub>1</sub> k<sub>−</sub>/σ and b<sub>2</sub> = k<sub>−</sub>/σ. In order to visualize the quality of the fits, we have plotted results in terms of the effective off rate (see <xref rid="fig5" ref-type="fig">Figure 5</xref>), k<sup>∗</sup><sub>off</sub> = b<sub>2</sub> k<sub>off</sub>/(k<sub>on</sub> + b<sub>2</sub>), where b<sub>2</sub> is determined from the fit (see above). The effective off rate for the molecular flexibility model is simply k<sub>off</sub> exp(b<sub>2</sub> ΔC<sub>p</sub>), where b<sub>2</sub> is a fitted parameter.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>al-Ramadi</surname>
              <given-names>B.K.</given-names>
            </name>
            <name>
              <surname>Jelonek</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Boyd</surname>
              <given-names>L.F.</given-names>
            </name>
            <name>
              <surname>Margulies</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Bothwell</surname>
              <given-names>A.L.</given-names>
            </name>
          </person-group>
          <article-title>Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR</article-title>
          <source>J. Immunol.</source>
          <volume>155</volume>
          <year>1995</year>
          <fpage>662</fpage>
          <lpage>673</lpage>
          <pub-id pub-id-type="pmid">7541822</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andersen</surname>
              <given-names>P.S.</given-names>
            </name>
            <name>
              <surname>Geisler</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Buus</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mariuzza</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Karjalainen</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Role of the T cell receptor ligand affinity in T cell activation by bacterial superantigens</article-title>
          <source>J. Biol. Chem.</source>
          <volume>276</volume>
          <year>2001</year>
          <fpage>33452</fpage>
          <lpage>33457</lpage>
          <pub-id pub-id-type="pmid">11397806</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Apostolopoulos</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>McKenzie</surname>
              <given-names>I.F.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>I.A.</given-names>
            </name>
          </person-group>
          <article-title>Structural implications for the design of molecular vaccines</article-title>
          <source>Curr. Opin. Mol. Ther.</source>
          <volume>2</volume>
          <year>2000</year>
          <fpage>29</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="pmid">11249650</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baker</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Gagnon</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Wiley</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Biddison</surname>
              <given-names>W.E.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a crucial energetic footprint on the alpha1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors</article-title>
          <source>J. Exp. Med.</source>
          <volume>193</volume>
          <year>2001</year>
          <fpage>551</fpage>
          <lpage>562</lpage>
          <pub-id pub-id-type="pmid">11238586</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beddoe</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Clements</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Ely</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Bushell</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Vivian</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Kjer-Nielsen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Dunstone</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.C.</given-names>
            </name>
          </person-group>
          <article-title>Antigen ligation triggers a conformational change within the constant domain of the alphabeta T cell receptor</article-title>
          <source>Immunity</source>
          <volume>30</volume>
          <year>2009</year>
          <fpage>777</fpage>
          <lpage>788</lpage>
          <pub-id pub-id-type="pmid">19464197</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bell</surname>
              <given-names>G.I.</given-names>
            </name>
          </person-group>
          <article-title>A theoretical model for adhesion between cells mediated by multivalent ligands</article-title>
          <source>Cell Biophys.</source>
          <volume>1</volume>
          <year>1979</year>
          <fpage>133</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">95173</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boulter</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Schmitz</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sewell</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Godkin</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Bachmann</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Gallimore</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Potent T cell agonism mediated by a very rapid TCR/pMHC interaction</article-title>
          <source>Eur. J. Immunol.</source>
          <volume>37</volume>
          <year>2007</year>
          <fpage>798</fpage>
          <lpage>806</lpage>
          <pub-id pub-id-type="pmid">17295390</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burroughs</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>van der Merwe</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Stochasticity and spatial heterogeneity in T-cell activation</article-title>
          <source>Immunol. Rev.</source>
          <volume>216</volume>
          <year>2007</year>
          <fpage>69</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">17367335</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carreño</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Bueno</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Bull</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Nathenson</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Kalergis</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge</article-title>
          <source>Immunology</source>
          <volume>121</volume>
          <year>2007</year>
          <fpage>227</fpage>
          <lpage>237</lpage>
          <pub-id pub-id-type="pmid">17313485</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cerundolo</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lamb</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cresswell</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>McMichael</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gotch</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Townsend</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Presentation of viral antigen controlled by a gene in the major histocompatibility complex</article-title>
          <source>Nature</source>
          <volume>345</volume>
          <year>1990</year>
          <fpage>449</fpage>
          <lpage>452</lpage>
          <pub-id pub-id-type="pmid">2342577</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y.T.</given-names>
            </name>
            <name>
              <surname>Scanlan</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Sahin</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Türeci</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Gure</surname>
              <given-names>A.O.</given-names>
            </name>
            <name>
              <surname>Tsang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Stockert</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Pfreundschuh</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Old</surname>
              <given-names>L.J.</given-names>
            </name>
          </person-group>
          <article-title>A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>94</volume>
          <year>1997</year>
          <fpage>1914</fpage>
          <lpage>1918</lpage>
          <pub-id pub-id-type="pmid">9050879</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Dunbar</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Gileadi</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Jäger</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Gnjatic</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Stockert</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Panicali</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.T.</given-names>
            </name>
            <name>
              <surname>Knuth</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL</article-title>
          <source>J. Immunol.</source>
          <volume>165</volume>
          <year>2000</year>
          <fpage>948</fpage>
          <lpage>955</lpage>
          <pub-id pub-id-type="pmid">10878370</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Stewart-Jones</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bossi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Lissin</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Wooldridge</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Held</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Dunbar</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Esnouf</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Sami</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Structural and kinetic basis for heightened immunogenicity of T cell vaccines</article-title>
          <source>J. Exp. Med.</source>
          <volume>201</volume>
          <year>2005</year>
          <fpage>1243</fpage>
          <lpage>1255</lpage>
          <pub-id pub-id-type="pmid">15837811</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chervin</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Holler</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Eisen</surname>
              <given-names>H.N.</given-names>
            </name>
            <name>
              <surname>Kranz</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>The impact of TCR-binding properties and antigen presentation format on T cell responsiveness</article-title>
          <source>J. Immunol.</source>
          <volume>183</volume>
          <year>2009</year>
          <fpage>1166</fpage>
          <lpage>1178</lpage>
          <pub-id pub-id-type="pmid">19553539</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choudhuri</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>van der Merwe</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Molecular mechanisms involved in T cell receptor triggering</article-title>
          <source>Semin. Immunol.</source>
          <volume>19</volume>
          <year>2007</year>
          <fpage>255</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="pmid">17560121</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choudhuri</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kearney</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>van der Merwe</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Immunology: How do T cells recognize antigen?</article-title>
          <source>Curr. Biol.</source>
          <volume>15</volume>
          <year>2005</year>
          <fpage>R382</fpage>
          <lpage>R385</lpage>
          <pub-id pub-id-type="pmid">15916940</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>van der Merwe</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>The structure and ligand interactions of CD2: Implications for T-cell function</article-title>
          <source>Immunol. Today</source>
          <volume>17</volume>
          <year>1996</year>
          <fpage>177</fpage>
          <lpage>187</lpage>
          <pub-id pub-id-type="pmid">8871350</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dushek</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Coombs</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of serial engagement and peptide-MHC transport in T cell receptor microclusters</article-title>
          <source>Biophys. J.</source>
          <volume>94</volume>
          <year>2008</year>
          <fpage>3447</fpage>
          <lpage>3460</lpage>
          <pub-id pub-id-type="pmid">18227132</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dushek</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Coombs</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>A role for rebinding in rapid and reliable T cell responses to antigen</article-title>
          <source>PLoS Comput. Biol.</source>
          <volume>5</volume>
          <year>2009</year>
          <fpage>e1000578</fpage>
          <pub-id pub-id-type="pmid">19956745</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Germain</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Stefanová</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>The dynamics of T cell receptor signaling: Complex orchestration and the key roles of tempo and cooperation</article-title>
          <source>Annu. Rev. Immunol.</source>
          <volume>17</volume>
          <year>1999</year>
          <fpage>467</fpage>
          <lpage>522</lpage>
          <pub-id pub-id-type="pmid">10358766</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>González</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Carreño</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Coombs</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Mora</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Palmieri</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Nathenson</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Kalergis</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>102</volume>
          <year>2005</year>
          <fpage>4824</fpage>
          <lpage>4829</lpage>
          <pub-id pub-id-type="pmid">15772168</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grakoui</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bromley</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Sumen</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Dustin</surname>
              <given-names>M.L.</given-names>
            </name>
          </person-group>
          <article-title>The immunological synapse: a molecular machine controlling T cell activation</article-title>
          <source>Science</source>
          <volume>285</volume>
          <year>1999</year>
          <fpage>221</fpage>
          <lpage>227</lpage>
          <pub-id pub-id-type="pmid">10398592</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holler</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>Kranz</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation</article-title>
          <source>Immunity</source>
          <volume>18</volume>
          <year>2003</year>
          <fpage>255</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">12594952</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hudrisier</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kessler</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Valitutti</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Horvath</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cerottini</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Luescher</surname>
              <given-names>I.F.</given-names>
            </name>
          </person-group>
          <article-title>The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement</article-title>
          <source>J. Immunol.</source>
          <volume>161</volume>
          <year>1998</year>
          <fpage>553</fpage>
          <lpage>562</lpage>
          <pub-id pub-id-type="pmid">9670927</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jäger</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.T.</given-names>
            </name>
            <name>
              <surname>Drijfhout</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Karbach</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ringhoffer</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jäger</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Arand</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Noguchi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Stockert</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes</article-title>
          <source>J. Exp. Med.</source>
          <volume>187</volume>
          <year>1998</year>
          <fpage>265</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="pmid">9432985</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalergis</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Boucheron</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Doucey</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Palmieri</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Goyarts</surname>
              <given-names>E.C.</given-names>
            </name>
            <name>
              <surname>Vegh</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Luescher</surname>
              <given-names>I.F.</given-names>
            </name>
            <name>
              <surname>Nathenson</surname>
              <given-names>S.G.</given-names>
            </name>
          </person-group>
          <article-title>Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex</article-title>
          <source>Nat. Immunol.</source>
          <volume>2</volume>
          <year>2001</year>
          <fpage>229</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="pmid">11224522</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kersh</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Essential flexibility in the T-cell recognition of antigen</article-title>
          <source>Nature</source>
          <volume>380</volume>
          <year>1996</year>
          <fpage>495</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="pmid">8606766</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kersh</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Kersh</surname>
              <given-names>E.N.</given-names>
            </name>
            <name>
              <surname>Fremont</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>High- and low-potency ligands with similar affinities for the TCR: The importance of kinetics in TCR signaling</article-title>
          <source>Immunity</source>
          <volume>9</volume>
          <year>1998</year>
          <fpage>817</fpage>
          <lpage>826</lpage>
          <pub-id pub-id-type="pmid">9881972</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krogsgaard</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Prado</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>X.L.</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>M.M.</given-names>
            </name>
          </person-group>
          <article-title>Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation</article-title>
          <source>Mol. Cell</source>
          <volume>12</volume>
          <year>2003</year>
          <fpage>1367</fpage>
          <lpage>1378</lpage>
          <pub-id pub-id-type="pmid">14690592</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Lauffenburger</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Linderman</surname>
              <given-names>J.J.</given-names>
            </name>
          </person-group>
          <chapter-title>Receptors: Models for Binding, Trafficking, and Signaling</chapter-title>
          <year>1993</year>
          <publisher-name>Oxford University Press</publisher-name>
          <publisher-loc>Oxford</publisher-loc>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leckband</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Measuring the forces that control protein interactions</article-title>
          <source>Annu. Rev. Biophys. Biomol. Struct.</source>
          <volume>29</volume>
          <year>2000</year>
          <fpage>1</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="pmid">10940241</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luxembourg</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Brunmark</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Sprent</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Requirements for stimulating naive CD8+ T cells via signal 1 alone</article-title>
          <source>J. Immunol.</source>
          <volume>161</volume>
          <year>1998</year>
          <fpage>5226</fpage>
          <lpage>5235</lpage>
          <pub-id pub-id-type="pmid">9820494</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Janmey</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Finkel</surname>
              <given-names>T.H.</given-names>
            </name>
          </person-group>
          <article-title>The receptor deformation model of TCR triggering</article-title>
          <source>FASEB J.</source>
          <volume>22</volume>
          <year>2008</year>
          <fpage>1002</fpage>
          <lpage>1008</lpage>
          <pub-id pub-id-type="pmid">17984179</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKeithan</surname>
              <given-names>T.W.</given-names>
            </name>
          </person-group>
          <article-title>Kinetic proofreading in T-cell receptor signal transduction</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>92</volume>
          <year>1995</year>
          <fpage>5042</fpage>
          <lpage>5046</lpage>
          <pub-id pub-id-type="pmid">7761445</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMahan</surname>
              <given-names>R.H.</given-names>
            </name>
            <name>
              <surname>McWilliams</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Dow</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Slansky</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines</article-title>
          <source>J. Clin. Invest.</source>
          <volume>116</volume>
          <year>2006</year>
          <fpage>2543</fpage>
          <lpage>2551</lpage>
          <pub-id pub-id-type="pmid">16932807</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Motulsky</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Christopoulos</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <chapter-title>Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting</chapter-title>
          <year>2004</year>
          <publisher-name>Oxford University Press</publisher-name>
          <publisher-loc>Oxford</publisher-loc>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Krogsgaard</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Chakraborty</surname>
              <given-names>A.K.</given-names>
            </name>
          </person-group>
          <article-title>Molecular flexibility can influence the stimulatory ability of receptor-ligand interactions at cell-cell junctions</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>103</volume>
          <year>2006</year>
          <fpage>4416</fpage>
          <lpage>4421</lpage>
          <pub-id pub-id-type="pmid">16537380</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Segura</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Guillaume</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Mark</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dojcinovic</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Johannsen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bosshard</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Angelov</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Legler</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Luescher</surname>
              <given-names>I.F.</given-names>
            </name>
          </person-group>
          <article-title>Increased mobility of major histocompatibility complex I-peptide complexes decreases the sensitivity of antigen recognition</article-title>
          <source>J. Biol. Chem.</source>
          <volume>283</volume>
          <year>2008</year>
          <fpage>24254</fpage>
          <lpage>24263</lpage>
          <pub-id pub-id-type="pmid">18579518</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shoup</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Role of diffusion in ligand binding to macromolecules and cell-bound receptors</article-title>
          <source>Biophys. J.</source>
          <volume>40</volume>
          <year>1982</year>
          <fpage>33</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">7139033</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Maile</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Frelinger</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate</article-title>
          <source>J. Immunol.</source>
          <volume>179</volume>
          <year>2007</year>
          <fpage>2952</fpage>
          <lpage>2960</lpage>
          <pub-id pub-id-type="pmid">17709510</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tolentino</surname>
              <given-names>T.P.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zarnitsyna</surname>
              <given-names>V.I.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Dustin</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Measuring diffusion and binding kinetics by contact area FRAP</article-title>
          <source>Biophys. J.</source>
          <volume>95</volume>
          <year>2008</year>
          <fpage>920</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="pmid">18390627</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van der Merwe</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>The TCR triggering puzzle</article-title>
          <source>Immunity</source>
          <volume>14</volume>
          <year>2001</year>
          <fpage>665</fpage>
          <lpage>668</lpage>
          <pub-id pub-id-type="pmid">11420037</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Webb</surname>
              <given-names>A.I.</given-names>
            </name>
            <name>
              <surname>Dunstone</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Aguilar</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kjer-Nielsen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Beddoe</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>McCluskey</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue</article-title>
          <source>J. Biol. Chem.</source>
          <volume>279</volume>
          <year>2004</year>
          <fpage>23438</fpage>
          <lpage>23446</lpage>
          <pub-id pub-id-type="pmid">15004033</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wettstein</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Boniface</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Reay</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Schild</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>M.M.</given-names>
            </name>
          </person-group>
          <article-title>Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH</article-title>
          <source>J. Exp. Med.</source>
          <volume>174</volume>
          <year>1991</year>
          <fpage>219</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">1829108</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app2" sec-type="supplementary-material">
      <title>Supplemental Information</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Supplemental Experimental Procedures, Three Figures, and Two Tables</title>
          </caption>
          <media xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank D. Shepherd for the supply of the 1G4 TCR expression plasmid and J. Byrne for the help with protein expression. We would also like to thank the reviewers for their constructive criticism. This work was supported by Cancer Research UK, the Medical Research Council (UK), the National Sciences and Engineering Research Council (Canada), and the Mathematics of Information Technology and Complex Systems National Centre of Excellence (Canada).</p>
    </ack>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Figure 1</label>
      <caption>
        <p>Binding Properties of 1G4 TCR Interaction with pMHC Variants</p>
        <p>Binding affinity and kinetics of 1G4 TCR interaction with a range of ESO-9V-HLA-A2 variants was measured at 37°C by SPR (see <xref rid="app2" ref-type="sec">Figure S1</xref>). Effect of peptide or HLA-A2 amino acid substitution on 1G4 TCR binding affinity and kinetics is presented as a fold difference compared to ESO-9V-HLA-A2. Substitutions that negatively affected 1G4 TCR binding have relative affinities and kinetics lower than 1. Values shown are the mean ± SEM of at least three independently performed experiments.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Figure 2</label>
      <caption>
        <p>Functional Response of 1G4 T Cells to pMHC Variants</p>
        <p>(A–C) IFN-γ release from 1G4 CTLs stimulated by plate-bound pMHC variants. 1G4 CTLs were cultured for 4 hr in 96-well plates coated with indicated concentrations of pMHC variants. Supernatants were collected and secreted IFN-γ was measured by ELISA. One of at least three independently performed experiments is shown.</p>
        <p>(D–E) Cytotoxic response of 1G4 CTLs to NY-ESO<sub>157-165</sub> peptide variants. A 1:1 ratio of 1G4 CTLs and <sup>51</sup>Cr-labeled T2 cells were pulsed with the indicated peptide dilutions starting from the concentration shown in previous experiments (<xref rid="app2" ref-type="sec">Figure S2</xref>D) to give a 40% increase in surface HLA-A2 expression (C<sub>40%</sub>) on T2 cells. After 4 hr incubation at 37°C, specific lysis of T2 cells was analyzed by measuring released <sup>51</sup>Cr. One of at least three independent experiments is shown.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Figure 3</label>
      <caption>
        <p>Correlation between T Cell Response and TCR-pMHC Binding Properties</p>
        <p>Correlations are shown between pMHC potency, represented by the concentration stimulating half-maximal IFN-γ secretion (EC<sub>50</sub>), and (A) the TCR-pMHC bond dissociation constant (K<sub>D</sub>), (B) the bond off rate (k<sub>off</sub>), (C) the bond on rate (k<sub>on</sub>), (D) the change in enthalpy (ΔH), and (E) activation enthalpy of dissociation (ΔH<sup>‡</sup><sub>diss</sub>). <xref rid="tbl1" ref-type="table">Table 1</xref> contains correlations with additional thermodynamic parameters. Significant correlations (p &lt; 0.05) are found only for K<sub>D</sub>, k<sub>off</sub>, and k<sub>on</sub> and other parameters that are directly derived from these. The R<sup>2</sup> statistic is the square of the correlation coefficient for these simple models and p values are computed with an F-test. Both quantities are calculated in Matlab with standard methods; see <xref rid="app2" ref-type="sec">Supplemental Information</xref> for details.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Figure 4</label>
      <caption>
        <p>Analysis of Model Fitting to Data Subsets with Larger Variability in the On Rate</p>
        <p>(A) The 17 pMHC variants that comprise the entire data set exhibit a large correlation between K<sub>D</sub> and k<sub>off</sub> (R<sup>2</sup> = 0.74). By systematically removing a fixed number of pMHC variants, we identified the subset that minimized the K<sub>D</sub>-k<sub>off</sub> correlation. For example, we calculated the correlation for all 17 possible subsets of 16 pMHC variants and selected the subset with the smallest K<sub>D</sub>-k<sub>off</sub> correlation.</p>
        <p>(B) The square of the K<sub>D</sub>-k<sub>off</sub> correlation as a function of the number of pMHC variants removed for the subset with the smallest correlation. In this way, we generated data sets with lower K<sub>D</sub>-k<sub>off</sub> correlations and hence larger variability in the on rate. Also shown in (B) is the R<sup>2</sup> statistic for fits of the K<sub>D,</sub> k<sub>off</sub>, molecular flexibility (MF), confinement time (CT), and the combined model (MF+CT) to all subsets considered. Computations for subsets consisting of less than eight pMHC variants did not provide reliable results because the number of parameters approached the number of data points.</p>
        <p>(C and D) The correlations of pMHC potency with K<sub>D</sub> and k<sub>off</sub> for the subset of 13 pMHC variants (i.e., when 4 pMHC variants are removed). See <xref rid="fig5" ref-type="fig">Figure 5</xref> for correlations with other models. In <xref rid="tbl2" ref-type="table">Table 2</xref> we report the p values associated with each fit, showing that when removing more than two pMHC variants, correlations with K<sub>D</sub> and k<sub>off</sub> are not significant (p &gt; 0.05). Also shown in <xref rid="tbl2" ref-type="table">Table 2</xref> are p values associated with an F-test that determines whether the additional parameter(s) in the CT, MF, and combined model is significant. The fitted parameters from each model are listed in <xref rid="app2" ref-type="sec">Table S2</xref>.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>Figure 5</label>
      <caption>
        <p>Correlation of pMHC Potency with Effective Off Rates</p>
        <p>(A) Model of TCR-pMHC confinement by rebinding. We used a mathematical model that accounted for a TCR-pMHC bound state (left), unbound but in physical proximity state (center), and a state where TCR and pMHC have moved apart (right). The rate of chemical dissociation is k<sub>off</sub> and the rate of association is k<sup>∗</sup><sub>on</sub> that is a first order rate, in units of s<sup>−1</sup>, that depends on the macroscopic on rate k<sub>on</sub>. When chemically dissociated (center), TCR-pMHC may move apart via diffusion or transport with a first order rate k<sub>−</sub>. We propose that the potency of pMHC is governed by the amount of time it is confined to the TCR. The effective off rate to go from bound (left) to complete dissociation (right), given that potentially many rebinding events may take place, is given by k<sup>∗</sup><sub>off</sub> = (k<sub>−</sub>k<sub>off</sub>)/(k<sup>∗</sup><sub>on</sub> + k<sub>−</sub>).</p>
        <p>(B–G) The panels show fits of the confinement time (CT), molecular flexibility (MF), and the combined (CT+MF) models to the entire data set (B, D, F) or the subset of 13 pMHC variants (C, E, G). The abscissa represents the effective off rate from each model. In the case of the confinement time model, it is (b<sub>2</sub>k<sub>off</sub>)/(k<sub>on</sub> + b<sub>2</sub>), where b<sub>2</sub> is a fitted parameter. In the case of the molecular flexibility model, the abscissa is k<sub>off</sub>exp(b<sub>2</sub>ΔC<sub>p</sub>), where b<sub>2</sub> is a fitted parameter. See <xref rid="sec4" ref-type="sec">Experimental Procedures</xref> for details on data fitting and representation of effective off rates.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <table-wrap id="tbl1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Correlation between pMHC Potency and TCR-pMHC Binding Parameters</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="2">TCR/pMHC Bond Parameter<xref rid="tblfn1" ref-type="table-fn">a</xref></th>
            <th colspan="2">IFN-γ Release (EC<sub>50</sub>)<xref rid="tblfn2" ref-type="table-fn">b</xref><hr/></th>
            <th colspan="2">Cytotoxicity (1/log(EC<sub>50</sub>))<xref rid="tblfn2" ref-type="table-fn">b</xref><hr/></th>
          </tr>
          <tr>
            <th>R<sup>2</sup></th>
            <th>p Value</th>
            <th>R<sup>2</sup></th>
            <th>p Value</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>K<sub>D</sub></td>
            <td align="char">0.719</td>
            <td align="char">1.70E-05</td>
            <td align="char">0.882</td>
            <td align="char">1.70E-04</td>
          </tr>
          <tr>
            <td>k<sub>off</sub></td>
            <td align="char">0.776</td>
            <td align="char">3.04E-06</td>
            <td align="char">0.960</td>
            <td align="char">3.73E-06</td>
          </tr>
          <tr>
            <td>t<sub>1/2</sub></td>
            <td align="char">0.358</td>
            <td align="char">0.0111</td>
            <td align="char">0.652</td>
            <td align="char">0.0085</td>
          </tr>
          <tr>
            <td>k<sub>on</sub></td>
            <td align="char">0.320</td>
            <td align="char">0.0179</td>
            <td align="char">0.633</td>
            <td align="char">0.0103</td>
          </tr>
          <tr>
            <td>1/k<sub>on</sub></td>
            <td align="char">0.012</td>
            <td align="char">0.6735</td>
            <td align="char">0.709</td>
            <td align="char">0.0044</td>
          </tr>
          <tr>
            <td>ΔG</td>
            <td align="char">0.624</td>
            <td align="char">0.0002</td>
            <td align="char">0.746</td>
            <td align="char">0.0027</td>
          </tr>
          <tr>
            <td>ΔH</td>
            <td align="char">0.077</td>
            <td align="char">0.2812</td>
            <td align="char">0.006</td>
            <td align="char">0.8424</td>
          </tr>
          <tr>
            <td>-TΔS</td>
            <td align="char">0.001</td>
            <td align="char">0.9064</td>
            <td align="char">0.044</td>
            <td align="char">0.5901</td>
          </tr>
          <tr>
            <td>ΔC</td>
            <td align="char">0.221</td>
            <td align="char">0.0569</td>
            <td align="char">0.110</td>
            <td align="char">0.3826</td>
          </tr>
          <tr>
            <td>ΔG<sup>‡</sup><sub>diss</sub></td>
            <td align="char">0.462</td>
            <td align="char">0.0027</td>
            <td align="char">0.603</td>
            <td align="char">0.0138</td>
          </tr>
          <tr>
            <td>ΔH<sup>‡</sup><sub>diss</sub></td>
            <td align="char">0.060</td>
            <td align="char">0.3443</td>
            <td align="char">0.108</td>
            <td align="char">0.3884</td>
          </tr>
          <tr>
            <td>-TΔS<sup>‡</sup><sub>diss</sub></td>
            <td align="char">0.036</td>
            <td align="char">0.4666</td>
            <td align="char">0.070</td>
            <td align="char">0.4921</td>
          </tr>
          <tr>
            <td>ΔC<sup>‡</sup><sub>diss</sub></td>
            <td align="char">0.047</td>
            <td align="char">0.4055</td>
            <td align="char">0.058</td>
            <td align="char">0.5327</td>
          </tr>
          <tr>
            <td>ΔG<sup>‡</sup><sub>ass</sub></td>
            <td align="char">0.202</td>
            <td align="char">0.0700</td>
            <td align="char">0.127</td>
            <td align="char">0.3469</td>
          </tr>
          <tr>
            <td>ΔH<sup>‡</sup><sub>ass</sub></td>
            <td align="char">0.098</td>
            <td align="char">0.2219</td>
            <td align="char">0.030</td>
            <td align="char">0.6539</td>
          </tr>
          <tr>
            <td>-TΔS<sup>‡</sup><sub>ass</sub></td>
            <td align="char">0.012</td>
            <td align="char">0.6793</td>
            <td align="char">0.082</td>
            <td align="char">0.4544</td>
          </tr>
          <tr>
            <td>ΔC<sup>‡</sup><sub>ass</sub></td>
            <td align="char">0.075</td>
            <td align="char">0.2891</td>
            <td align="char">0.034</td>
            <td align="char">0.6360</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn1">
          <label>a</label>
          <p>Measured EC<sub>50</sub> values are correlated to various TCR-pMHC bond parameters via data fitting in Matlab. Standard methods are used to calculate the R<sup>2</sup> statistic, which is the square of the correlation coefficient for these simple models, and p values are obtained with an F-test. Details can be found in the <xref rid="app2" ref-type="sec">Supplemental Information</xref>. The quality of the fit for several bond parameters is shown in <xref rid="fig3" ref-type="fig">Figure 3</xref>.</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tblfn2">
          <label>b</label>
          <p>We use the reciprocal of EC<sub>50</sub> for the cytotoxicity assay because it is obtained from a dilution curve. We take the log to account for effects of nonlinear loading of peptide to APCs. The use of EC<sub>50</sub> in both assays is discussed in the <xref rid="app2" ref-type="sec">Supplemental Information</xref>.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="tbl2" position="float">
      <label>Table 2</label>
      <caption>
        <p>Analysis of Model Fitting to Data Subsets</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="3">pMHCs Removed<xref rid="tblfn3" ref-type="table-fn">a</xref></th>
            <th rowspan="2">K<sub>D</sub> - k<sub>off</sub> Correlation<hr/></th>
            <th colspan="10">Goodness-of-Fit Statistics<xref rid="tblfn4" ref-type="table-fn">b</xref><hr/></th>
            <th colspan="5">F-Test for Model Comparison<xref rid="tblfn5" ref-type="table-fn">c</xref><hr/></th>
          </tr>
          <tr>
            <th colspan="2">K<sub>D</sub><hr/></th>
            <th colspan="2">k<sub>off</sub><hr/></th>
            <th colspan="2">CT<hr/></th>
            <th colspan="2">MF<hr/></th>
            <th colspan="2">CT+MF<hr/></th>
            <th>CT/K<sub>D</sub><hr/></th>
            <th>CT/k<sub>off</sub><hr/></th>
            <th>MF/k<sub>off</sub><hr/></th>
            <th>CT+MF/CM<hr/></th>
            <th>CT+MF/MF<hr/></th>
          </tr>
          <tr>
            <th>R<sup>2</sup></th>
            <th>R<sup>2</sup></th>
            <th>p</th>
            <th>R<sup>2</sup></th>
            <th>p</th>
            <th>R<sup>2</sup></th>
            <th>p</th>
            <th>R<sup>2</sup></th>
            <th>p</th>
            <th>R<sup>2</sup></th>
            <th>p</th>
            <th>p</th>
            <th>p</th>
            <th>p</th>
            <th>p</th>
            <th>p</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>0</td>
            <td align="char">0.74</td>
            <td align="char">0.72</td>
            <td align="char">1.70E-05</td>
            <td align="char">0.78</td>
            <td align="char">3.04E-06</td>
            <td align="char">0.83</td>
            <td align="char">3.94E-06</td>
            <td align="char">0.78</td>
            <td align="char">2.14E-05</td>
            <td align="char">0.89</td>
            <td align="char">2.12E-06</td>
            <td align="char">0.009</td>
            <td align="char">0.051</td>
            <td align="char">0.461</td>
            <td align="char">0.026</td>
            <td align="char">0.005</td>
          </tr>
          <tr>
            <td>1</td>
            <td align="char">0.54</td>
            <td align="char">0.59</td>
            <td align="char">0.0005</td>
            <td align="char">0.65</td>
            <td align="char">0.0002</td>
            <td align="char">0.74</td>
            <td align="char">0.0001</td>
            <td align="char">0.70</td>
            <td align="char">0.0004</td>
            <td align="char">0.84</td>
            <td align="char">4.31E-05</td>
            <td align="char">0.014</td>
            <td align="char">0.043</td>
            <td align="char">0.166</td>
            <td align="char">0.019</td>
            <td align="char">0.006</td>
          </tr>
          <tr>
            <td>2</td>
            <td align="char">0.39</td>
            <td align="char">0.47</td>
            <td align="char">0.0048</td>
            <td align="char">0.53</td>
            <td align="char">0.0021</td>
            <td align="char">0.66</td>
            <td align="char">0.0015</td>
            <td align="char">0.61</td>
            <td align="char">0.0038</td>
            <td align="char">0.80</td>
            <td align="char">0.0004</td>
            <td align="char">0.023</td>
            <td align="char">0.052</td>
            <td align="char">0.155</td>
            <td align="char">0.019</td>
            <td align="char">0.008</td>
          </tr>
          <tr>
            <td>3</td>
            <td align="char">0.18</td>
            <td align="char">0.26</td>
            <td align="char">0.0621</td>
            <td align="char">0.24</td>
            <td align="char">0.0763</td>
            <td align="char">0.40</td>
            <td align="char">0.0577</td>
            <td align="char">0.34</td>
            <td align="char">0.0993</td>
            <td align="char">0.60</td>
            <td align="char">0.0235</td>
            <td align="char">0.131</td>
            <td align="char">0.108</td>
            <td align="char">0.213</td>
            <td align="char">0.054</td>
            <td align="char">0.031</td>
          </tr>
          <tr>
            <td>4</td>
            <td align="char">1.2E-03</td>
            <td align="char">0.26</td>
            <td align="char">0.0738</td>
            <td align="char">0.21</td>
            <td align="char">0.1187</td>
            <td align="char">0.68</td>
            <td align="char">0.0034</td>
            <td align="char">0.31</td>
            <td align="char">0.1563</td>
            <td align="char">0.73</td>
            <td align="char">0.0062</td>
            <td align="char">0.005</td>
            <td align="char">0.003</td>
            <td align="char">0.249</td>
            <td align="char">0.224</td>
            <td align="char">0.005</td>
          </tr>
          <tr>
            <td>5</td>
            <td align="char">1.0E-04</td>
            <td align="char">0.26</td>
            <td align="char">0.0876</td>
            <td align="char">0.14</td>
            <td align="char">0.2309</td>
            <td align="char">0.65</td>
            <td align="char">0.0085</td>
            <td align="char">0.59</td>
            <td align="char">0.0177</td>
            <td align="char">0.79</td>
            <td align="char">0.0041</td>
            <td align="char">0.011</td>
            <td align="char">0.005</td>
            <td align="char">0.012</td>
            <td align="char">0.048</td>
            <td align="char">0.024</td>
          </tr>
          <tr>
            <td>6</td>
            <td align="char">4.4E-07</td>
            <td align="char">0.27</td>
            <td align="char">0.1050</td>
            <td align="char">0.21</td>
            <td align="char">0.1588</td>
            <td align="char">0.69</td>
            <td align="char">0.0095</td>
            <td align="char">0.32</td>
            <td align="char">0.2112</td>
            <td align="char">0.76</td>
            <td align="char">0.0150</td>
            <td align="char">0.011</td>
            <td align="char">0.008</td>
            <td align="char">0.279</td>
            <td align="char">0.205</td>
            <td align="char">0.010</td>
          </tr>
          <tr>
            <td>7</td>
            <td align="char">1.2E-07</td>
            <td align="char">0.26</td>
            <td align="char">0.1313</td>
            <td align="char">0.15</td>
            <td align="char">0.2666</td>
            <td align="char">0.69</td>
            <td align="char">0.0157</td>
            <td align="char">0.58</td>
            <td align="char">0.0468</td>
            <td align="char">0.79</td>
            <td align="char">0.0191</td>
            <td align="char">0.016</td>
            <td align="char">0.010</td>
            <td align="char">0.031</td>
            <td align="char">0.156</td>
            <td align="char">0.053</td>
          </tr>
          <tr>
            <td>8</td>
            <td align="char">1.5E-09</td>
            <td align="char">0.20</td>
            <td align="char">0.2229</td>
            <td align="char">0.20</td>
            <td align="char">0.2271</td>
            <td align="char">0.64</td>
            <td align="char">0.0463</td>
            <td align="char">0.29</td>
            <td align="char">0.3561</td>
            <td align="char">0.71</td>
            <td align="char">0.0833</td>
            <td align="char">0.035</td>
            <td align="char">0.035</td>
            <td align="char">0.414</td>
            <td align="char">0.332</td>
            <td align="char">0.044</td>
          </tr>
          <tr>
            <td>9</td>
            <td align="char">6.3E-07</td>
            <td align="char">0.26</td>
            <td align="char">0.2004</td>
            <td align="char">0.20</td>
            <td align="char">0.2602</td>
            <td align="char">0.72</td>
            <td align="char">0.0400</td>
            <td align="char">0.31</td>
            <td align="char">0.3965</td>
            <td align="char">0.76</td>
            <td align="char">0.0994</td>
            <td align="char">0.033</td>
            <td align="char">0.028</td>
            <td align="char">0.424</td>
            <td align="char">0.486</td>
            <td align="char">0.052</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn3">
          <label>a</label>
          <p>The first row corresponds to the entire data set of 17 pMHC variants and the last row, where nine pMHC are removed, corresponds to the subset of eight pMHC variants. Each subset represents the set of pMHC variants that minimize the K<sub>D</sub>-k<sub>off</sub> correlation. See <xref rid="sec2" ref-type="sec">Results</xref> and <xref rid="fig4" ref-type="fig">Figure 4</xref> for details on subset analysis. The quality of the fit for K<sub>D</sub> and k<sub>off</sub> models are shown in <xref rid="fig3" ref-type="fig">Figures 3</xref>A and 3B (entire data set) and <xref rid="fig4" ref-type="fig">Figures 4</xref>C and 4D (subset of 13 pMHC variants).</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tblfn4">
          <label>b</label>
          <p>R<sup>2</sup> and p values are calculated based on the quality of the fit and the number of free parameters for each model (see <xref rid="sec4" ref-type="sec">Experimental Procedures</xref> for details). Abbreviations: CT, confinement time model; MF, molecular flexibility model; CT+MF, combined confinement and flexibility models. The quality of the fit for the CT, MF, and CT+MF models are shown in <xref rid="fig5" ref-type="fig">Figure 5</xref> for the entire data set (B, D, F) and for the subset of 13 pMHC variants (C, E, G).</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tblfn5">
          <label>c</label>
          <p>F-test provides a p value for the null hypothesis that the simpler model (with fewer parameters) is sufficient to explain the data. Simpler models are shown after the slash. Details are provided in the <xref rid="sec4" ref-type="sec">Experimental Procedures</xref>.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>